A diabetes pill developed by Bristol-Myers (BMY) and AstraZeneca (AZN) was effective in a Phase...


A diabetes pill developed by Bristol-Myers (BMY) and AstraZeneca (AZN) was effective in a Phase III study, although the trial produced increased cases of bladder and breast cancers. The drug, dapagliflozin, is set to be reviewed by an FDA advisory committee in July.

From other sites
Comments (6)
  • tailspin
    , contributor
    Comments (35) | Send Message
     
    This is ridiculous. Forget about pills. Go on a low/no carb/sugar/alkohol 500 - 700 cal diet for an extended period and exercise modestly. That has resolved sustainably all of my cholesterol/ diabetes/ high blood/ high weight problems that I was carrying with me for at least 20 years. Realize that pills are taken mostly to continue with unsound eating and drinking habits. But they dont resolve the underlying problem.
    26 Jun 2011, 09:03 AM Reply Like
  • Ken Hasner
    , contributor
    Comments (425) | Send Message
     
    You are correct but in situations where the pancreas' ability to produce insulin has been destroyed by years of poor habits some folks have no choice. But good advice for those in early stages of disease.
    26 Jun 2011, 12:16 PM Reply Like
  • coloneldebugger
    , contributor
    Comments (920) | Send Message
     
    why is a something that knowingly is causing cancer even being considered for further study?
    26 Jun 2011, 01:50 PM Reply Like
  • Ken Hasner
    , contributor
    Comments (425) | Send Message
     
    Have you ever heard of the big pharma lobby ?
    26 Jun 2011, 01:53 PM Reply Like
  • JohnBinTN
    , contributor
    Comments (4428) | Send Message
     
    The 'chance' of getting cancer may be more attractive than the certainty of dying. Just a guess.
    27 Jun 2011, 12:59 AM Reply Like
  • StickyKind
    , contributor
    Comment (1) | Send Message
     
    Hey Seeking Alpha,
    Drug stock you should be talking about is in the BB.
    ELTP. It has an amazing chart.
    Great potential in the oxy market. That market has been in the news as of lately (ACUR PTIE DRXX).
    This stock just traded past its 50 Moving average. Conference call this week.

     

    ELTP to double/ triple in the next few weeks.
    26 Jun 2011, 03:41 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs